Clinical trial

Anecortave Acetate in Patients With Open-angle Glaucoma

NCT00320203

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-03-01

PhasePHASE2

Study timeline

Study start (unknown)2006-03-01Date precision: month

Registry last updated2012-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open-angle Glaucomaunresolved

Interventions

Anecortave Acetate Sterile Suspension, 6 mg/mLDRUG

Anecortave Acetate Sterile Suspension, 30 mg/mLDRUG

Anecortave Acetate Sterile Suspension, 60 mg/mLDRUG

Anecortave Acetate VehicleOTHER

Sponsors & collaborators

Alcon Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00320203 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.